DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin formulated to reduce dosing frequency and have a low incidence of side effects. The application was a
Melior Discovery has developed expertise in screening compounds for potential therapeutic activity in animal models. Melior is expected to apply this expertise to the evaluation of large numbers
The acquisition includes Orchid’s beta-lactam antibiotic formulations manufacturing complex (comprising cephalosporin, penicillin and carbapenem facilities) and pharmaceutical research and development (R&D) facility at Irungattukottai, Chennai, as well as
Revenues totaled $1.4m, as compared to $3m during the same period in 2008, a decrease of 54%. The decrease in revenues was primarily due to a decrease in
The parties to the agreement are: California-based AMC, Hong Kong-based Delta Group Investments (DGI) and Washington-based TNS. AMC is a highly experienced direct mail marketing company. DGI is
The study results included demonstration that lymphocyte counts in the vascular space were reduced in a dose-related fashion. As such, Lpath achieved an objective established by Merck KGaA
COT said that in the study, animals were divided into three study groups: Group 1 (Control) animals received vehicle only (no treatment), Group 2 (Pretreatment) animals received oral
Nutra Pharma claimed that Cobroxin is clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet,
As per the terms of the agreement Pfenex is eligible to receive maintenance fees, milestone payments as well as royalty payments on any product sales derived from the
Renovo said that the trial has now recruited over 350 patients from 55 centres in 10 countries: UK, France, Hungary, Germany, Italy, Poland, Spain, Denmark, Latvia and USA.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.